Effects of a 5-HT2 receptor agonist and an antagonist on the behavior of rats with different choices of reinforcement value

被引:0
|
作者
Zaichenko M.I. [1 ]
Merzhanova G.Kh. [1 ]
Vanetsian G.L. [1 ]
机构
[1] Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow
关键词
DOI; impulsivity; ketanserin; rats; serotonin;
D O I
10.1007/s11055-014-9940-3
中图分类号
学科分类号
摘要
The effects of the 5-HT2 receptor agonist DOI ((±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride) and the antagonist ketanserin (ketanserin tartrate salt) were studied in rats using the "right to choose" reinforcement value method. Depending on the preferred food reinforcement choice, the rats were divided into self-controlled (selecting the more valuable but delayed reinforcement) and impulsiv (preferring low-value but rapid reinforcement) groups. Animals received intraperitoneal DOI or ketanserin at a dose of 0.2 mg/kg 1 h before testing. Behavioral parameters were measured - the number of pressing of the two pedals, the latent periods of opening the screen and pressing the pedal, and the number of missed screen shifting/pedal pressing reactions. Administration of ketanserin produced a statistically significant increase in selection of the low-value, immediate reinforcement in the group of impulsive animals but did not alter the behavior of self-controlled animals. After administration of DOI, neither of the groups showed any statistically significant changes in reinforcement choice, though studies of the actions of this agent demonstrated statistically significant reductions in impulsivity in all animals, regardless of division into typological groups. In some cases, DOI decreased the number of missed reactions, while ketanserin decreased the latent period of responses. © 2014 Springer Science+Business Media.
引用
收藏
页码:506 / 512
页数:6
相关论文
共 50 条
  • [1] Effects of a 5-HT2 receptor agonist (DOI) and a 5-HT2A receptor antagonist (ketanserin) on interval timing behaviour
    Body, S
    Kheramin, S
    Ho, MY
    Miranda, F
    Bradshaw, CM
    Szabadi, E
    JOURNAL OF PSYCHOPHARMACOLOGY, 2003, 17 (03) : A69 - A69
  • [2] HEMORHEOLOGICAL EFFECTS OF A 5-HT2 RECEPTOR ANTAGONIST (KETANSERIN)
    BOGAR, L
    MATRAI, A
    WALKER, RT
    FLUTE, PT
    DORMANDY, JA
    CLINICAL HEMORHEOLOGY, 1985, 5 (02): : 115 - 121
  • [3] Effect of Agonists and Antagonists of 5-HT2 Receptors on Rats with Different Choice of Reinforcement Value
    Zaichenko, M. I.
    Merzhanova, G. Kh
    Vanetsian, G. L.
    ZHURNAL VYSSHEI NERVNOI DEYATELNOSTI IMENI I P PAVLOVA, 2013, 63 (02) : 246 - 255
  • [4] Restraint accentuates the effects of 5-HT2 receptor antagonists and a 5-HT1A receptor agonist on lordosis behavior
    Uphouse, L
    White, S
    Harrison, L
    Hiegel, C
    Majumdar, D
    Guptarak, J
    Truitt, WA
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2003, 76 (01) : 63 - 73
  • [5] Ketanserin, a 5-HT2 receptor antagonist, reduces sleep apneas in rats
    Radulovacki, MN
    Pavlovic, S
    Rakic, A
    Janelidze, M
    Carley, DW
    SLEEP, 2001, 24 : A279 - A279
  • [6] PROPERTY OF PHENCYCLIDINE AS A 5-HT2 RECEPTOR AGONIST
    NABESHIMA, T
    ISHIKAWA, K
    YAMAGUCHI, K
    FURUKAWA, H
    KAMEYAMA, T
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 28 (01) : 134 - 134
  • [7] PHARMACOLOGICAL PROFILE OF (-)HT-90B, A NOVEL 5-HT1A RECEPTOR AGONIST 5-HT2 RECEPTOR ANTAGONIST
    UCHIDA, H
    INAGAWA, K
    TAMEDA, C
    MIYAUCHI, T
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1995, 19 (07): : 1201 - 1216
  • [8] Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats:: Differential roles of 5-HT2 receptor subtypes
    Yonezawa, Akihiko
    Yoshizumi, Masaru
    Ebiko, Manabu
    Ise, Shin-Nosuke
    Watanabe, Chizuko
    Mizoguchi, Hirokazu
    Kimura, Yukio
    Sakurada, Shinobu
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2008, 88 (04) : 367 - 373
  • [9] 5-HT2 receptor activation:: A common denominator of the NMDA antagonist and 5-HT2A agonist models of psychosis?
    Vollenweider, FX
    Bächle, D
    Leenders, KL
    Missimer, J
    Hell, D
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 129S - 130S
  • [10] KETANSERIN - A SELECTIVE 5-HT2 RECEPTOR ANTAGONIST
    KOCH, H
    PHARMACY INTERNATIONAL, 1982, 3 (08): : 244 - 245